Exploring how cytoplasmic capping affects gene regulation
Understanding the mechanisms that regulate cytoplasmic capping and defining its contributions to post-transcriptional gene regulation
This study is looking at how a special cap is added to certain RNA molecules in our cells, which helps control how genes work, and it aims to find out what triggers this process, so we can better understand how it might help in treating different diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10868570 on NIH RePORTER |
What this research studies
This research investigates the process of cytoplasmic capping, where a specific molecular cap is added to mRNA in the cytoplasm, which is crucial for regulating gene expression. The study aims to identify the RNA sequences that trigger this capping process and understand its role in controlling the fate of mRNAs, particularly those that are truncated. By combining data mining and advanced sequencing techniques, the research seeks to uncover the mechanisms behind this regulatory pathway, which could have implications for various diseases. Patients may benefit from insights gained about gene regulation that could lead to new therapeutic strategies.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with genetic disorders or conditions related to mRNA processing and regulation.
Not a fit: Patients with conditions unrelated to gene regulation or mRNA processing may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new approaches for treating diseases linked to gene regulation abnormalities.
How similar studies have performed: While the specific focus on cytoplasmic capping is relatively novel, similar research approaches have shown promise in understanding post-transcriptional regulation.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Kiss, Daniel Louis — Methodist Hospital Research Institute
- Study coordinator: Kiss, Daniel Louis
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.